Cellectar Biosciences Inc (NAS:CLRB)
$ 2.501 +0.030 (+1.2%) Market Cap: 19.99 Mil Enterprise Value: 13.84 Mil PE Ratio: 0 PB Ratio: 3.82 GF Score: 28/100

Cellectar Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 09:30 PM GMT
Release Date Price: $4.04 (+6.32%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CLRB.OQ - Cellectar Biosciences Inc
Cellectar Biosciences Inc at JPMorgan Healthcare Conference
Jan 13, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Yeah, no, the Cubs, who are you talking about?

Redmond, he's a cop.

He's a coup.

He's a cop.

It's $35 million a year.

Good afternoon. Welcome back to session. My name is Matt Gardner. I'll be your moderator for this afternoon. Our first presenting company in the afternoon session is Select our Biosciences from Florham Park, New Jersey. As a Westfield guy, I'm a great pride introducing you here, Jim. So, Selectar is focused on oncology, platform technology, and radio pharmaceuticals, and presenting for Select R is Jim Crusoe.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot